Mylan’s Media Storm
August 25, 2016
Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model
1 min read

August 25, 2016
Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model
1 min read
August 23, 2016
1 min read
August 23, 2016
1 min read
August 23, 2016
Protection at the genetic level – a new line of defense against contamination in biopharmaceutical manufacturing
1 min read
August 19, 2016
1 min read
August 19, 2016
1 min read
August 19, 2016
1 min read
August 17, 2016
The latest edition of the European Pharmacopoeia was published in July 2016 and some large changes are afoot. The industry is more globalized than ever before, and a greater range of international experts are being encouraged to get involved with setting and maintaining standards.
1 min read
August 17, 2016
Are you stuck at a Five Sigma improvement project? Or is Quality-by-Design based product development too cumbersome? Many people struggle with QbD, but there are secrets to success.
1 min read
August 17, 2016
Is innovation in small-molecule drugs dead? Certainly not – large molecules may grab the bulk of industry headlines, but small-molecule drugs are still pulling their weight. Ongoing research into improving small-molecule manufacturing is just as relevant in the age of biopharma.
1 min read
False
False